TRIGGER
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 22, No. 21 November 2, 2016
_________________________________
_________________________________
UPCOMING MEETINGS EVENTS
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 22, No. 21 November 2, 2016
(The next issue will be on November 15, 2016)
TRIGGER is also available by RSS Feed:
PAPERS IN PRESS
None Submitted for this issue.UPCOMING MEETINGS EVENTS
General info on upcoming meetings of interest:
http://tf7.org/meetings.htm
_________________________________
ISTH also maintains a list of upcoming meetings of interest:
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
Papers are culled from NLM MedLine (PubMed). Titles in square brackets indicate that the paper was not published in English. References that lack volume or page numbers are typically electronic pre-publications (E-pubs) ahead of the print publication; if so, the final citation with volume and page numbers may or may not appear in a future issue of Trigger.
THE FOLLOWING LINK WILL TAKE YOU TO THE ENTIRE LIST OF THIS ISSUE'S PUBLICATIONS IN A PUBMED "COLLECTION":
Antoniak S, Mackman N (2016) Letter to Editor response:
Endothelial cell tissue factor and coagulation. Trends Cardiovasc Med.
Arakawa N, Kobayashi H, Yonemoto N, Masuishi Y, Ino Y,
Shigetomi H, . . . Miyagi E (2016) Clinical Significance of Tissue
Factor Pathway Inhibitor 2, a Serum Biomarker Candidate for Ovarian Clear Cell
Carcinoma. PLoS One 11:e0165609.
Aronis KN, Hylek EM (2016) Who, when, and how to reverse
non-vitamin K oral anticoagulants. J Thromb Thrombolysis 41:253-272.
Branchini A, Ferrarese M, Lombardi S, Mari R, Bernardi F,
Pinotti M (2016) Differential functional readthrough over
homozygous nonsense mutations contributes to the bleeding phenotype in
coagulation factor VII deficiency. J Thromb Haemost 14:1994-2000.
Breitenstein A, Stampfli SF, Reiner MF, Shi Y, Keller S,
Akhmedov A, . . . Camici GG (2016) The MAP kinase JNK2 mediates cigarette
smoke-induced arterial thrombosis. Thromb Haemost 117.
Chen X, Wu J, Huang H, Ding Q, Liu X, Chen L, . . . Xia T
(2016) Comparative Profiling of Triple-Negative Breast Carcinomas Tissue
Glycoproteome by Sequential Purification of Glycoproteins and Stable Isotope
Labeling. Cell Physiol Biochem 38:110-121.
Chudzinski-Tavassi AM, Morais KL, Pacheco MT, Pasqualoto
KF, de Souza JG (2016) Tick salivary gland as potential natural source for the
discovery of promising antitumor drug candidates. Biomed Pharmacother 77:14-19.
Cramer TJ, Anderson K, Navaz K, Brown JM, Mosnier LO, von
Drygalski A (2016) Heterozygous congenital Factor VII deficiency with
the 9729del4 mutation, associated with severe spontaneous
intracranial bleeding in an adolescent male. Blood Cells Mol Dis 57:8-12.
Daniel JM, Reichel CA, Schmidt-Woell T, Dutzmann J,
Zuchtriegel G, Krombach F, . . . Kanse SM (2016) Factor VII-activating protease
deficiency promotes neointima formation by enhancing leukocyte accumulation. J
Thromb Haemost 14:2058-2067.
Davies J, Kadir R (2016) The Management of Factor XI
Deficiency in Pregnancy. Semin Thromb Hemost 42:732-740.
Dennis J, Truong V, Aissi D, Medina-Rivera A, Blankenberg
S, Germain M, . . . Gagnon F (2016) Single nucleotide polymorphisms in an
intergenic chromosome 2q region associated with tissue factor pathway inhibitor
plasma levels and venous thromboembolism. J Thromb Haemost 14:1960-1970.
Desborough M, Estcourt LJ, Doree C, Trivella M, Hopewell
S, Stanworth SJ, Murphy MF (2016) Alternatives, and adjuncts, to prophylactic
platelet transfusion for people with haematological malignancies undergoing intensive
chemotherapy or stem cell transplantation. Cochrane Database Syst Rev:CD010982.
Desborough M, Hadjinicolaou AV, Chaimani A, Trivella M,
Vyas P, Doree C, . . . Estcourt LJ (2016) Alternative agents to prophylactic
platelet transfusion for preventing bleeding in people with thrombocytopenia
due to chronic bone marrow failure: a meta-analysis and systematic review.
Cochrane Database Syst Rev 10:CD012055.
Desborough MJ, Smethurst PA, Estcourt LJ, Stanworth SJ
(2016) Alternatives to allogeneic platelet transfusion. Br J Haematol
175:381-392.
El-Sayed OM, Dewyer NA, Luke CE, Elfline M, Laser A,
Hogaboam C, . . . Henke PK (2016) Intact Toll-like receptor 9 signaling
in neutrophils modulates normal thrombogenesis in mice. J Vasc Surg
64:1450-1458 e1451.
Fazavana JG, Muczynski V, Proulle V, Wohner N, Christophe
OD, Lenting PJ, Denis CV (2016) LDL receptor-related protein 1 contributes to
the clearance of the activated factor VII-antithrombin complex. J Thromb Haemost.
Gadomska G, Stankowska K, Boinska J, Bartoszewska-Kubiak
A, Haus O, Rosc D (2016) Activation of the tissue factor-dependent extrinsic
pathway and its relation to JAK2 V617F mutation status in patients with
essential thrombocythemia. Blood Coagul Fibrinolysis 27:817-821.
Gissel M, Brummel-Ziedins KE, Butenas S, Pusateri AE,
Mann KG, Orfeo T (2016) Effects of an acidic environment on coagulation
dynamics. J Thromb Haemost 14:2001-2010.
Grandone E, Chinni E, Villani M, Scianname N, Tiscia GL,
Favuzzi G, . . . Margaglione M (2016) Modulation of factors involved
in placental haemostasis and angiogenesis by low-molecular-weight-heparins.
Arch Gynecol Obstet 294:1323-1329.
Kessler CM, Ma AD, Al-Mondhiry HA, Gut RZ, Cooper DL
(2016) Assessment of acquired hemophilia patient demographics in the United States: the Hemostasis and Thrombosis Research Society
Registry. Blood Coagul Fibrinolysis 27:761-769.
Kumral D, Caldwell SH, Argo CK (2016) Impact of an
Institutional Change in Prothrombin Time Methodology on INR and MELD Scores in
Liver Transplant Evaluations. J Clin Lab Anal 30:968-971.
Laplante P, Fuentes R, Salem D, Subang R, Gillis MA,
Hachem A, . . . Rauch J (2016) Antiphospholipid antibody-mediated effects
in an arterial model of thrombosis are dependent on Toll-like receptor 4. Lupus 25:162-176.
Leiderman K, Chang WC, Ovanesov M, Fogelson AL (2016)
Synergy Between Tissue Factor and Exogenous Factor XIa in Initiating
Coagulation. Arterioscler Thromb Vasc Biol.
Li W, Chen W, Xie M, Huang H, Su H, Han H, . . . Wei J (2016)
Fasudil inhibits tissue factor and plasminogen activator Inhibitor-1 secretion
by peripheral blood mononuclear cells in CAPD patients. Ren Fail:1-5.
Liang G, Bowen JP (2016) Development of Trypsin-Like Serine
Protease Inhibitors as Therapeutic Agents: Opportunities, Challenges, and their
Unique Structure-Based Rationales. Curr Top Med Chem 16:1506-1529.
Liu H, Chen X, Xue W, Chu C, Liu Y, Tong H, . . . Zhang W
(2016) Recombinant epidermal growth factor-like domain-1 from coagulation
factor VII functionalized iron oxide nanoparticles for targeted glioma magnetic
resonance imaging. Int J Nanomedicine 11:5099-5108.
Liu T, Zhang X, Ke B, Wang Y, Wu X, Jiang G, . . . Nie G
(2016) F-127-PEI co-delivering docetaxel and TFPI-2 plasmid for nasopharyngeal
cancer therapy. Mater Sci Eng C Mater Biol Appl 61:269-277.
Lopez-Vilchez I, Diaz-Ricart M, Galan AM, Roque M,
Caballo C, Molina P, . . . Escolar G (2016) Internalization of Tissue
Factor-Rich Microvesicles by Platelets Occurs Independently of GPIIb-IIIa, and
Involves CD36 Receptor, Serotonin Transporter and Cytoskeletal Assembly. J Cell
Biochem 117:448-457.
Ly K, Essalmani R, Desjardins R, Seidah NG, Day R (2016)
An Unbiased Mass Spectrometry Approach Identifies Glypican-3 as an Interactor
of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) and LDL Receptor in
Hepatocellular Carcinoma Cells. J Biol Chem.
Ma AD, Kessler CM, Al-Mondhiry HA, Gut RZ, Cooper DL
(2016) Use of recombinant activated factor VII for acute bleeding episodes in
acquired hemophilia: final analysis from the Hemostasis and Thrombosis Research
Society Registry acquired hemophilia study. Blood Coagul Fibrinolysis
27:753-760.
Marco W, Ursula R (2016) Letter to the Editor: Tissue
factor of endothelial origin: Just another brick in the wall? Trends Cardiovasc
Med.
Matsumoto H, Yamakawa K, Ogura H, Koh T, Matsumoto N,
Shimazu T (2016) Clinical Significance of Tissue Factor and CD13
Double-Positive Microparticles in Sirs Patients with Trauma and Severe Sepsis.
Shock.
Meiring M, Allers W, Le Roux E (2016) Tissue factor: A
potent stimulator of Von Willebrand factor synthesis by human umbilical vein
endothelial cells. Int J Med Sci 13:759-764.
Miyata N, Isaka M, Kojima H, Maniwa T, Takahashi S,
Takamiya O, Ohde Y (2016) Continuous infusion of recombinant activated factor
VII for bleeding control after lobectomy in a patient with inherited factor VII
deficiency. Gen Thorac Cardiovasc Surg 64:177-180.
Nogueira MR, Latini AC, Nogueira ME (2016) The
involvement of endothelial mediators in leprosy. Mem Inst Oswaldo Cruz
111:635-641.
Paulus E, Komperda K, Park G, Fusco J (2016)
Anticoagulation Therapy Considerations in Factor VII Deficiency. Drug Saf Case
Rep 3:8.
Pehrsson S, Hansson K, Nelander K, Nylander S (2016)
Boosting the coagulation restores haemostasis in ticagrelor-treated mice. Blood
Coagul Fibrinolysis 27:913-919.
Peyvandi F, Garagiola I, Biguzzi E (2016) Advances in the
treatment of bleeding disorders. J Thromb Haemost.
Polderdijk SG, Adams TE, Ivanciu L, Camire RM, Baglin TP,
Huntington JA (2016) Design and characterization of an APC-specific serpin for
the treatment of hemophilia. Blood.
Puy C, Tucker EI, Ivanov IS, Gailani D, Smith SA,
Morrissey JH, . . . McCarty OJ (2016) Platelet-Derived Short-Chain
Polyphosphates Enhance the Inactivation of Tissue Factor Pathway Inhibitor by
Activated Coagulation Factor XI. PLoS One 11:e0165172.
Ragab SM, Soliman MA (2016) Tissue factor-positive
monocytes expression in children with sickle cell disease: clinical implication
and relation to inflammatory and coagulation markers. Blood Coagul Fibrinolysis
27:862-869.
Reddy M, Tawfik B, Gavva C, Yates S, De Simone N, Hofmann
SL, . . . Sarode R (2016) Ischemic stroke in a patient with
moderate to severe inherited factor VII deficiency. Transfus Apher Sci.
Rollin J, Pouplard C, Gruel Y (2016) Risk factors for
heparin-induced thrombocytopenia: Focus on Fcgamma receptors. Thromb
Haemost 116:799-805.
Sakurai M, Matsumoto K, Gosho M, Sakata A, Hosokawa Y,
Tenjimbayashi Y, . . . Satoh T (2016) Expression of Tissue Factor in Epithelial
Ovarian Carcinoma Is Involved in the Development of Venous Thromboembolism. Int
J Gynecol Cancer.
Schenk B, Wurtinger P, Streif W, Sturm W, Fries D, Bachler
M (2016) Ex vivo reversal of effects of rivaroxaban evaluated using
thromboelastometry and thrombin generation assay. Br J Anaesth 117:583-591.
Shahbazi S, Khorasani M, Mahdian R (2016) Gene expression
profile of FVII and AR in primary prostate cancer. Cancer Biomark 17:353-358.
Shi W, Yin Y, Wang Y, Zhang B, Tan P, Jiang T, . . . Hu Y
(2016) A tissue factor-cascade-targeted strategy to tumor vasculature: a combination
of EGFP-EGF1 conjugation nanoparticles with photodynamic therapy. Oncotarget.
Shima M (2016) Trends in novel treatments for hemophilia.
Rinsho Ketsueki 57:2259-2266.
Sun DS, Ho PH, Chang HH (2016) Soluble P-selectin rescues
viper venom-induced mortality through anti-inflammatory properties and PSGL-1 pathway-mediated correction of hemostasis. Sci Rep
6:35868.
Toogeh G, Abolghasemi H, Eshghi P, Managhchi M,
Shaverdi-Niasari M, Karimi K, . . . Abdollahi A (2016) Evaluation of Aryoseven
Safety (Recombinant Activated Factor VII) in Patients with Bleeding Disorders
(An Observational Post-Marketing Surveillance Study). Iran J Pathol 11:204-209.
Vadivel K, Kumar Y, Ogueli GI, Ponnuraj SM,
Wongkongkathep P, Loo JA, . . . Bajaj SP (2016) S2'-subsite variations between
human and mouse enzymes (plasmin, factor XIa, kallikrein) elucidate inhibition
differences by TFPI-2 domain1-wildtype, Leu17Arg-mutant and aprotinin. J Thromb
Haemost.
van Doorn P, Rosing J, Wielders SJ, Hackeng TM, Castoldi
E (2016) The C-terminus of tissue factor pathway inhibitor-alpha inhibits
factor V activation by protecting the Arg1545 cleavage site. J Thromb Haemost.
Williams MS, Cushman M, Ouyang P, Heckbert SR, Kalyani
RR, Vaidya D (2016) Association of Serum Sex Hormones with Hemostatic
Factors in Women On and Off Hormone Therapy: The Multiethnic Study of
Atherosclerosis. J Womens Health (Larchmt) 25:166-172.
Willner D, Spennati V, Stohl S, Tosti G, Aloisio S,
Bilotta F (2016) Spine Surgery and Blood Loss: Systematic Review of Clinical
Evidence. Anesth Analg 123:1307-1315.
Yamaguchi R, Yamamoto T, Sakamoto A, Ishimaru Y, Narahara
S, Sugiuchi H, Yamaguchi Y (2016) Substance P enhances tissue factor release
from granulocyte-macrophage colony-stimulating factor-dependent macrophages via
the p22phox/beta-arrestin 2/Rho A signaling pathway. Blood Cells Mol Dis 57:85-90.
Zhao XP, He SW, Yue B, Wang GH, Zhang M (2016) Molecular
characterization, expression analysis, and bactericidal activity of the
derivative peptides of TFPI-1 and TFPI-2 in half-smooth tongue sole,
Cynoglossus semilaevis. Fish Shellfish Immunol 58:563-571.
Zhu S, Herbig BA, Li R, Colace TV, Muthard RW, Neeves KB,
Diamond SL (2015) In microfluidico: Recreating in vivo hemodynamics
using miniaturized devices. Biorheology 52:303-318.
Zhu S, Lu Y, Sinno T, Diamond SL (2016) Dynamics of
Thrombin Generation and Flux from Clots during Whole Human Blood Flow over
Collagen/Tissue Factor Surfaces. J Biol Chem 291:23027-23035.
_________________________________TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.
DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
_________________________________
